In a more recent study, LC-MS-based multi-omics analyses were used to investigate the mechanism of resistance to Palbociclib [76].This therapeutic drug is a specific CDK4/6 inhibitor that has been widely used in the therapy of various forms of cancer. This evidence concerns the gene CDK4 and cancer.